Home/News/Market context Source: Investing.com ↗ UBS raises Jazz Pharmaceuticals stock price target on Ziihera approval Published Sep 11, 2026 13:52 UTC | Translation unavailable. Please try again. Original report Read the original report on Investing.com ↗ Recommended marketsNo specific asset was identified in this report; browse live USDT reference pairs.Browse markets → USDC/USDT $1.00 -0.01% BTC/USDT $86,220.00 +0.83% ETH/USDT $2,745.81 +0.47% ZEC/USDT $1,622.37 +6.88% XRP/USDT $1.61 +5.75%